07.31.12
Nathealth Solutions, Reno, NV, has announced the U.S. launch of a clinically validated nutritional supplement that targets a number of risk factors associated with metabolic syndrome. BergaMet MEGA, the patented extract of the citrus fruit bergamot, targets cholesterol, blood pressure, blood glucose and abdominal obesity, and the major components of metabolic syndrome without any demonstrated side effects. Available in Australia and Europe, BergaMet MEGA is now available to consumers and health care professionals in the U.S.. Multiple peer-reviewed journals have published reports on bergamot fruit’s ability to reduce total cholesterol of approximately 30%, reduce LDL (bad) cholesterol up to 38%, reduce triglycerides of up to 40%, increase HDL (good) cholesterol of up to 42%, and reduce blood sugar levels 20-30%.